Zepos & Yannopoulos is proud to have supported Piraeus Bank as Greek legal counsel on the financing of Pharmathen's acquisition of CBL Patras, a prominent FDA-approved peptide manufacturer and supplier in Europe. This deal signifies a remarkable milestone in the pharmaceutical landscape, as it forges synergies through vertical integration and broadens the product portfolio of both companies.
We have advised Piraeus Bank in relation to the entire spectrum of banking and corporate law matters of the deal, including the negotiation of the finance documents and advice on the bankability of the SPA. Allen & Overy LLP, with a team led by partner Robert Burt, acted as Piraeus Bank’s English law counsel.
We are excited to have played a role in this deal and pledge to maintain our active role in the M&A financing ecosystem by continuing to apply a pragmatic and business-focused approach.
Our core team consisted of Paris Tzoumas, partner, and Dimitra Androulakaki, associate of the Finance & Capital Markets practice group.
